Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...